Klotho Neurosciences Total Risk Alpha

KLTODelisted Stock   0.47  -0.05  -9.62%   
The Total Risk Alpha indicator for Klotho Neurosciences is constructed from normalized market data. All inputs reflect available trading data across supported markets. Some instruments may report limited inputs depending on trading history. Klotho Neurosciences has a market cap of 56.21 M, ROE of -1.98%. Use Correlation Analysis to explore allocation context. The allocation summary reflects available position data. This includes a position in Klotho Neurosciences. The allocation reflects this within the position set. Each holding is sized according to the methodology applied to the portfolio. This view summarizes available data without implying outcomes. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Klotho Neurosciences has current Total Risk Alpha of 1.76. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.

Total Risk Alpha

 = 

RFR + (ER[b] - ER[a])

x

STD[a] / STD[b]

 = 
1.76
ER[a] = Expected return on investing in Klotho Neurosciences
ER[b] = Expected return on market index or selected benchmark
STD[a] =   Standard Deviation of returns on Klotho Neurosciences
STD[b] = Standard Deviation of selected market or benchmark
RFR = Risk Free Rate of return. Typically T-Bill Rate

Total Risk Alpha Peers Comparison

Total Risk Alpha Relative To Other Indicators

Klotho Neurosciences lands at #3 in total risk alpha compared to key competitors. It is currently under evaluation in maximum drawdown compared to key competitors producing 50.11 in Maximum Drawdown for each unit of Total Risk Alpha. The spread between Maximum Drawdown and Total Risk Alpha for Klotho Neurosciences sits at 50.11
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund. Compare Klotho Neurosciences to Peers

Other Technical Indicators